President Donald Trump speaks at a Nov. 20 news conference in the briefing room at the White House (Susan Walsh/AP)

November 20, 2020 04:27 PM EST

With only weeks left in his presidency, Trump makes a final, long-shot bid to remake US drug pricing

Max Gelman

Senior Editor

As the curtain closes on his administration, President Donald Trump is using his final weeks in office to push one of his longest-running campaign promises …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

With only weeks left in his presidency, Trump makes a final, long-shot bid to remake US drug pricing

Max Gelman

Senior Editor

Sign up to read this article for free.

Trump taps Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, surgeon general picks

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

From vaccines to psychedelics, five drugmakers on what could change under a Trump administration

Sanofi introduces new 340B payment model — report

Patient dies in Neurogene's Rett syndrome study

With on­ly weeks left in his pres­i­den­cy, Trump makes a fi­nal, long-shot bid to re­make US drug pric­ing

Max Gelman

Senior Editor

Sign up to read this article for free.

more like this

Trump taps Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, sur­geon gen­er­al picks

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

Sanofi in­tro­duces new 340B pay­ment mod­el — re­port

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

With only weeks left in his presidency, Trump makes a final, long-shot bid to remake US drug pricing

Trump taps Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, surgeon general picks

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

From vaccines to psychedelics, five drugmakers on what could change under a Trump administration

Sanofi introduces new 340B payment model — report

Patient dies in Neurogene's Rett syndrome study